Research ArticleClinical Studies

Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study

CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS and ANDERS R. HOLMBERG
Anticancer Research December 2016, 36 (12) 6499-6504;

Article Information

vol. 36 no. 12 6499-6504
PubMed 
27919973
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received October 25, 2016
  • Revision received November 9, 2016
  • Accepted November 14, 2016
  • Published online December 5, 2016.
Copyright & Usage 
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. CAMILLA THELLENBERG-KARLSSON3,
  2. CLAES NYMAN2,
  3. STEN NILSSON1,
  4. RENÉ BLOM4,
  5. MARCELA MÁRQUEZ1,
  6. ENRIQUE CASTELLANOS1 and
  7. ANDERS R. HOLMBERG1⇑
  1. 1Karolinska Institute, CCK/R8/00, Stockholm, Sweden
  2. 2Stockholm South General Hospital, Stockholm, Sweden
  3. 3Norrlands University Hospital, Umeå, Sweden
  4. 4Skånes University Hospital, Lund, Sweden
  1. Correspondence to: Dr. Anders R. Holmberg, Karolinska Institute, CCK/R8/00, S-17176 Stockholm, Sweden. Tel: +46 733242782, e-mail: arh{at}telia.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Bone-targeted Novel Cytotoxic Polybisphosphonate Conjugate in Castration-resistant Prostate Cancer: A Multicenter Phase 1 Study
CAMILLA THELLENBERG-KARLSSON, CLAES NYMAN, STEN NILSSON, RENÉ BLOM, MARCELA MÁRQUEZ, ENRIQUE CASTELLANOS, ANDERS R. HOLMBERG
Anticancer Research Dec 2016, 36 (12) 6499-6504;
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords